HealthcareServices

Global Single-Cell Genome Sequencing Market Report 2026–2035: Key Forecasts and Growth Areas

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the single-cell genome sequencing market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Single-Cell Genome Sequencing Market show for the 2026–2030 period?

The single-cell genome sequencing market size has seen rapid expansion in recent years. Its value is projected to climb from $2.83 billion in 2025 to $3.26 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.2%. The historical growth of this market is attributable to early adoption in research, limited sequencing resolution, the high cost of single-cell analysis, a growing demand for personalized medicine research, and increasing collaborations in genomics.

The single-cell genome sequencing market is anticipated to experience substantial growth in the coming years. This market is projected to reach $5.84 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.7%. Several factors contribute to this expansion during the forecast period, including the development of high-throughput single-cell platforms, increased use in clinical diagnostics, integration with AI and bioinformatics, broader adoption in multi-omics studies, and growth in drug discovery applications. Furthermore, major trends expected during this forecast period involve increasing application in cancer research, continued integration with multi-omics studies, wider adoption in drug discovery, the advancement of automated sequencing platforms, and an expansion in clinical diagnostics applications.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp

What Drivers Are Shaping The Development Of The Single-Cell Genome Sequencing Market?

The increasing incidence of cancer is anticipated to drive the growth of the single-cell genome sequencing market. Cancer describes a wide array of conditions where abnormal cells multiply and divide without control, stemming from changes in genes that regulate cell division and normal cellular function. Given that cancer is characterized by genetic alterations, single-cell genome sequencing provides a means to identify the genetic modifications within individual cancer cells. For example, in January 2023, the American Cancer Society, a US-based organization dedicated to fighting cancer, reported approximately 1.9 million new cancer cases and 609,360 cancer deaths in the US in 2022. Furthermore, projections estimate around 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. Consequently, the rising prevalence of cancer is expected to propel the expansion of the single-cell genome sequencing market.

Which Segments Are Contributing To The Growth Of The Single-Cell Genome Sequencing Market?

The single-cell genome sequencing market covered in this report is segmented –

1) By Type: Instruments, Reagents

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)

3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas

4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications

5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users

Subsegments:

1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems

2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents

Which Trends Are Shaping Activity Within The Single-Cell Genome Sequencing Market?

Leading firms in the single-cell genome sequencing market are concentrating on the advancement of single cell proteomics. This emerging field, single cell proteomics, aims to understand the diverse protein expression present within individual cells. It involves combining single-cell genomics with proteomics methods to investigate the link between genomic data and protein expression at the individual cell level. As an illustration, in October 2023, Proteome Sciences plc, a biotechnology firm based in the UK, introduced SysQuant SCP, a commercial single-cell proteomics service utilizing its TMTproTM isobaric labelling reagents. The SysQuant SCP pipeline generates and analyzes quantitative mass spectrometry data to detect subtle differences in individual cells and within subpopulations of the same primary cell type. This information will substantially enhance our knowledge of the biological factors influencing heterogeneity and evolution in disease and treatment response contexts, by identifying new therapeutic and diagnostic targets for personalized medicine.

Who Are The Primary Competitors In The Global Single-Cell Genome Sequencing Market?

Major companies operating in the single-cell genome sequencing market are F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Single-Cell Genome Sequencing Market?

North America was the largest region in the single-cell genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Single-Cell Genome Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12655&type=smp

Browse Through More Reports Similar to the Global Single-Cell Genome Sequencing Market 2026, By The Business Research Company

Metagenomic Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Single Cell Analysis Market 2026

https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market

Whole Genome And Exome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795